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VentriculitisTuberculous ventriculitis is an inflammatory infection of the ventricular system of the
brain, and is caused by Mycobacterium tuberculosis. We herein present the case of an
immunocompromised patient with brain tuberculomas who developed ventriculitis during
treatment. The patient was successfully treated with a high dose of steroid, long-term anti-
tuberculosis drugs, and aggressive supportive care.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.Introduction
In 2014, there were 9.6 million cases of tuberculosis (TB)
worldwide, with reports estimating 1.5 million deaths globally
due to this infection [1]. Central nervous system TB (CNS-TB)
accounts for 1% of all TB cases, and has the highest mortality
than other forms of the disease [2]. The pathogen Mycobac-
terium tuberculosis may invade the CNS following primary
infection by inhalation, filtering by regional draining lymph
nodes, low-level bacteremia, and metastatic seeding. Reacti-
vation of the organisms in the CNS results in different syn-
dromes, with meningitis being the most prevalent
presentation of CNS-TB [3]. A proportion of patients with
CNS-TB have also been reported to experience complicationsduring the various phases of the disease. Common complica-
tions of CNS-TB are cranial nerve paresis and hydrocephalus
[4]. One of the rare and devastating complications of the dis-
ease is ventriculitis. Tuberculous ventriculitis occurs follow-
ing enlargement, extension, and rupture of a tubercle in the
ventricular system [5]. We herein describe the case of an
immunocompromised patient with intracranial tuberculo-
mas, who developed ventriculitis during treatment.
Case report
A 37-year-old man was admitted to our hospital for evalua-
tion of photophobia, diplopia, and deterioration of mental
status, which he was experiencing for the last 2 days. Heue, Fatemi
Fig. 1 – Contrast-enhanced T1-weighted brain magnetic
resonance imaging shows meningeal enhancement, a ring-
enhanced lesion in the right occipital lobe with cystic
formation, and peripheral edema and another lesion in the
left insular lobe in the (A) axial, (B) parasagittal, and (C)
coronal views on admission.
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monary TB for the last 3 weeks in another hospital. TB was
documented by detection of M. tuberculosis in two separate
sputum smear staining. On admission, he looked ill (blood
pressure 135/88 mmHg, pulse 96 heart beats/min, respiratory
rate 26 breaths/min, temperature 36.7 C). Systemic examina-
tion was unremarkable, except for Cushing’s face and crack-
les in both lungs. Neurological examination showed
drowsiness, unclear speech, ataxia, and decreased deep ten-
don reflexes in four limbs. Laboratory finding was normal
except for anemia (hemoglobin 10.3 mg/dL) and a high ery-
throcyte sedimentation rate (107 mm/h; normal range: up to
20 mm/h). Brain contrast-enhanced magnetic resonance
imaging (MRI) showed meningeal enhancement and two
ring-enhanced lesions in the right occipital lobe and the left
insular lobe (Fig. 1). We investigated for other possible diag-
noses such as pyogenic and fungal brain abscess, toxoplas-
mosis, and endocarditis by serologic and routine
microbiological assays. In this situation, intravenous broad-
spectrum antimicrobial treatment and steroid therapy were
initiated. Owing to the documentation of pulmonary TB by
sputum smear staining and endemicity of TB in our region,
the patient received anti-TB drugs with a standard dose,
which consisted of isoniazid (5 mg/kg), rifampin (10 mg/kg),
pyrazinamide (25 mg/kg), and ethambutol (15 mg/kg), for cra-
nial lesions.
The clinical condition of the patient improved for a few
days. Further examinations for other possible diagnoses were
all negative. On hospitalization day 26, he was developed a
sudden loss of consciousness, high-grade fever, generalized
tonic–colonic seizure, and respiratory distress. At that time,
his vital signs were as follows: blood pressure 183/85 mmHg,
pulse rate 84 heart beats/min, respiratory rate 28 breaths/
min, and temperature 39 C. Results of neurological examina-
tions revealed a light comatose state, papilledema, nuchal
rigidity, and lower limbs hypotonia. The second brain MRI
showed mild hydrocephalus, enlargement of the posterior
lesion with extension into the right occipital horn of the lat-
eral ventricles, ependymal enhancement with some ventricu-
lar sludge, and periventricular edema, compatible with
ventriculitis (Fig. 2). Hence, we started treatment with anti-
convulsants, high dose of intravenous steroid, which was
24-mg daily divided dose of dexamethasone with any
required supportive care. He also developed an episode of
hospital-acquired infection (HAI) during this period, which
was managed by broad-spectrum antimicrobials. Improve-
ment occurred gradually over the ensuing weeks. The patient
was discharged with relative amelioration on hospital day 44.
The patient continued to receive anti-TB drugs and low-dose
oral steroid for 1 year. In the 2nd-year follow-up, the patient
was completely cured with no sign of reactivation.Discussion
Ventriculitis, also called ‘‘ependymitis”, is an inflammation of
the ventricular system of the brain. It usually develops after
neurosurgical interventions, and Staphylococcus species are
the predominant microorganisms, identifiable in more than
90% of the cases. There are also rare reports of unusual causesof ventriculitis, such as those caused by M. tuberculosis [6].
Enlargement of brain tuberculomas during treatment is
reported in about one third of patients [7] as a sign of para-
doxical TB-associated immune reconstitution inflammatory
syndrome [8], which has a 13% mortality rate [9]. In very
exceptional cases, an enlarged tubercle may extend or rup-
ture into the ventricular system, resulting in ventriculitis.
Despite endemicity of TB in many countries, only limited
reports of this complication have been found in the literature.
Ventriculitis is accompanied by vigorous neurological
symptoms and devastating clinical condition. Symptoms of
ventriculitis in our patient were seizure, papilledema,
meningismus, and worsening of the underlying disease.
These symptoms are comparable to the report presented by
Fig. 2 – After 4 weeks of treatment, the second brain
magnetic resonance imaging shows mild hydrocephalus,
enlargement of the posterior lesion with extension into the
right occipital horn of the lateral ventricles, resulting in
ependymal enhancement with some ventricular sludge,
which is compatible with ventriculitis in the (A) axial, (B)
parasagittal, and (C) coronal views.
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ventriculitis. Furthermore, another report of fatal tuberculous
ventriculitis in an infant has also been presented [11]. A
recent study [12] reported the case of an old patient with
silent tuberculous ventriculitis presenting with symptoms of
memory loss and drowsiness [12]. Common radiological
findings in our patient and in all of these reports werehydrocephalus, ventricular sludge, and ependymal and
meningeal enhancement.
The main treatment regimen in our patient and in the
patient described by Guler et al. [12] was medical manage-
ment based on anti-TB drugs. However, in two other reports
[10,11], five of six patients underwent operative intervention
for severe complications, such as hydrocephalus. High-dose
steroid is another principal component of the treatment in
all the patients, but it raises the concern of developing a sec-
ondary infection. The final prognosis in our patient was
recovery; however, among the seven previously reported
cases, two patients died [10–12]. We think that the essential
keys for the successful management of our patient were con-
trol of intracranial inflammation, management of HAI, long-
term TB treatment, plenary supportive care, and avoidance
of unnecessary operative intervention.
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